share_log

MoonLake Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%), etc.

MoonLake Immunotherapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Kenneth Griffin(3.4%),Citadel Advisors LLC(3.3%)等

SEC announcement ·  02/14 17:04
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息